General Healthcare - European Medical Journal

Continue

General Healthcare

Filter
EMJ
1 Jun 2014

Walking Month in May 2014

As you may have noticed across our social platforms this month, we have been spreading the awareness of National Walking Month 2014.
EMJ
26 May 2014

Scientists Discover Potential New Target for Cancer Immunotherapy

Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and…
EMJ
13 May 2014

Scientists Find New Way to Mobilize Immune System against Viruses

University of British Columbia scientists have uncovered an intricate chain reaction in the body’s immune system and have used the knowledge to develop…
EMJ
9 May 2014

New Method Sneaks Drugs into Cancer Cells before Triggering Release

Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before…
EMJ
11 Apr 2014

Review of Testosterone-Containing Medicines Started

The European Medicines Agency has started a review of testosterone-containing medicines, mainly used in men who do not produce enough testosterone…
EMJ
30 Mar 2014

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14
EMJ
27 Mar 2014

Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between…
EMJ
27 Mar 2014

Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to…
We’ve noticed you’re accessing
from North/South America.